Hany Massarany - Net Worth and Insider Trading
Hany Massarany Net Worth
The estimated net worth of Hany Massarany is at least $33 Million dollars as of 2024-12-14. Hany Massarany is the President and CEO of GenMark Diagnostics Inc and owns about 1,346,742 shares of GenMark Diagnostics Inc (GNMK) stock worth over $32 Million. Hany Massarany is the Director of Biodesix Inc and owns about 337,131 shares of Biodesix Inc (BDSX) stock worth over $451,756. Hany Massarany is also the Director of Accelerate Diagnostics Inc and owns about 3,000 shares of Accelerate Diagnostics Inc (AXDX) stock worth over $3,930. Details can be seen in Hany Massarany's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hany Massarany has not made any transactions after 2024-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hany Massarany
Hany Massarany Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hany Massarany owns 3 companies in total, including GenMark Diagnostics Inc (GNMK) , Accelerate Diagnostics Inc (AXDX) , and Biodesix Inc (BDSX) .
Click here to see the complete history of Hany Massarany’s form 4 insider trades.
Insider Ownership Summary of Hany Massarany
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GNMK | GenMark Diagnostics Inc | 2020-01-23 | director & President and CEO |
| AXDX | Accelerate Diagnostics Inc | 2022-01-31 | director |
| BDSX | Biodesix Inc | 2024-11-05 | director |
Hany Massarany Latest Holdings Summary
Hany Massarany currently owns a total of 3 stocks. Among these stocks, Hany Massarany owns 1,346,742 shares of GenMark Diagnostics Inc (GNMK) as of January 23, 2020, with a value of $32 Million and a weighting of 98.61%. Hany Massarany owns 337,131 shares of Biodesix Inc (BDSX) as of November 5, 2024, with a value of $451,756 and a weighting of 1.38%. Hany Massarany also owns 3,000 shares of Accelerate Diagnostics Inc (AXDX) as of January 31, 2022, with a value of $3,930 and a weighting of 0.01%.
Latest Holdings of Hany Massarany
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GNMK | GenMark Diagnostics Inc | 2020-01-23 | 1,346,742 | 24.04 | 32,375,678 |
| BDSX | Biodesix Inc | 2024-11-05 | 337,131 | 1.34 | 451,756 |
| AXDX | Accelerate Diagnostics Inc | 2022-01-31 | 3,000 | 1.31 | 3,930 |
Holding Weightings of Hany Massarany
Hany Massarany Form 4 Trading Tracker
According to the SEC Form 4 filings, Hany Massarany has made a total of 1 transactions in GenMark Diagnostics Inc (GNMK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in GenMark Diagnostics Inc is the sale of 28,920 shares on January 23, 2020, which brought Hany Massarany around $141,708.
According to the SEC Form 4 filings, Hany Massarany has made a total of 3 transactions in Biodesix Inc (BDSX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biodesix Inc is the acquisition of 22,500 shares on November 5, 2024, which cost Hany Massarany around $30,825.
According to the SEC Form 4 filings, Hany Massarany has made a total of 2 transactions in Accelerate Diagnostics Inc (AXDX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Accelerate Diagnostics Inc is the acquisition of 2,000 shares on January 31, 2022, which cost Hany Massarany around $66,000.
Insider Trading History of Hany Massarany
- 1
Hany Massarany Trading Performance
GuruFocus tracks the stock performance after each of Hany Massarany's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hany Massarany is 42.02%. GuruFocus also compares Hany Massarany's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hany Massarany within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hany Massarany's insider trading performs compared to the benchmark.
Performance of Hany Massarany
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.03 | | | | | |
| Relative Return to S&P 500(%) | 12.35 | | | | | |
Hany Massarany Ownership Network
Ownership Network List of Hany Massarany
Ownership Network Relation of Hany Massarany
Hany Massarany Owned Company Details
What does GenMark Diagnostics Inc do?
Who are the key executives at GenMark Diagnostics Inc?
Hany Massarany is the director & President and CEO of GenMark Diagnostics Inc. Other key executives at GenMark Diagnostics Inc include SVP & Engineering and Tech Dev Tyler Jensen , VP & Assay Development Christine Shaw , and VP & Qual & Reg & & Clin Affairs Alan Baer Maderazo .
GenMark Diagnostics Inc (GNMK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of GenMark Diagnostics Inc (GNMK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GenMark Diagnostics Inc (GNMK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
GenMark Diagnostics Inc (GNMK)'s detailed insider trading history can be found in Insider Trading Tracker table.
GenMark Diagnostics Inc Insider Transactions
Hany Massarany Mailing Address
Above is the net worth, insider trading, and ownership report for Hany Massarany. You might contact Hany Massarany via mailing address: 1910 Innovation Park Dr, Tucson Az 85737.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
